Literature DB >> 18713619

LDL protein nitration: implication for LDL protein unfolding.

Ryan T Hamilton1, Liana Asatryan, Jon T Nilsen, Jose M Isas, Timothy K Gallaher, Tatsuya Sawamura, Tzung K Hsiai.   

Abstract

Oxidatively- or enzymatically-modified low-density lipoprotein (LDL) is intimately involved in the initiation and progression of atherosclerosis. The in vivo modified LDL is electro-negative (LDL(-)) and consists of peroxidized lipid and unfolded apoB-100 protein. This study was aimed at establishing specific protein modifications and conformational changes in LDL(-) assessed by liquid chromatography/tandem mass spectrometry (LC/MS/MS) and circular dichroism analyses, respectively. The functional significance of these chemical modifications and structural changes were validated with binding and uptake experiments to- and by bovine aortic endothelial cells (BAEC). The plasma LDL(-) fraction showed increased nitrotyrosine and lipid peroxide content as well as a greater cysteine oxidation as compared with native- and total-LDL. LC/MS/MS analyses of LDL(-) revealed specific modifications in the apoB-100 moiety, largely involving nitration of tyrosines in the alpha-helical structures and beta(2) sheet as well as cysteine oxidation to cysteic acid in beta(1) sheet. Circular dichroism analyses showed that the alpha-helical content of LDL(-) was substantially lower ( approximately 25%) than that of native LDL ( approximately 90%); conversely, LDL(-) showed greater content of beta-sheet and random coil structure, in agreement with unfolding of the protein. These results were mimicked by treatment of LDL subfractions with peroxynitrite (ONOO(-)) or SIN-1: similar amino acid modifications as well as conformational changes (loss of alpha-helical structure and gain in beta-sheet structure) were observed. Both LDL(-) and ONOO(-)-treated LDL showed a statistically significant increase in binding and uptake to- and by BAEC compared to native LDL. We further found that most binding and uptake in control-LDL was through LDL-R with minimal oxLDL-R-dependent uptake. ONOO(-)-treated LDL was significantly bound and endocytosed by LOX-1, CD36, and SR-A with minimal contribution from LDL-R. It is suggested that lipid peroxidation and protein nitration may account for the mechanisms leading to apoB-100 protein unfolding and consequential increase in modified LDL binding and uptake to and by endothelial cells that is dependent on oxLDL scavenger receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713619      PMCID: PMC2649963          DOI: 10.1016/j.abb.2008.07.026

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  34 in total

1.  Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.

Authors:  S R Thomas; M J Davies; R Stocker
Journal:  Chem Res Toxicol       Date:  1998-05       Impact factor: 3.739

2.  Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation.

Authors:  S L Hazen; J R Crowley; D M Mueller; J W Heinecke
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

3.  LDL- is a lipid hydroperoxide-enriched circulating lipoprotein.

Authors:  A Sevanian; G Bittolo-Bon; G Cazzolato; H Hodis; J Hwang; A Zamburlini; M Maiorino; F Ursini
Journal:  J Lipid Res       Date:  1997-03       Impact factor: 5.922

4.  High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry.

Authors:  A Ducret; I Van Oostveen; J K Eng; J R Yates; R Aebersold
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

5.  Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima.

Authors:  C Leeuwenburgh; M M Hardy; S L Hazen; P Wagner; S Oh-ishi; U P Steinbrecher; J W Heinecke
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

6.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.

Authors:  Yu Yamaguchi; Sachiko Matsuno; Satomi Kagota; Jun Haginaka; Masaru Kunitomo
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

8.  Role of beta2-glycoprotein I, LDL-, and antioxidant levels in hypercholesterolemic elderly subjects.

Authors:  Ligia F Gomes; André F Alves; Alex Sevanian; Clóvis de Araújo Peres; Maysa S Cendoroglo; Clineu de Mello-Almada; Lara M Quirino; Luiz R Ramos; Virgínia B C Junqueira
Journal:  Antioxid Redox Signal       Date:  2004-04       Impact factor: 8.401

9.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-).

Authors:  H N Hodis; D M Kramsch; P Avogaro; G Bittolo-Bon; G Cazzolato; J Hwang; H Peterson; A Sevanian
Journal:  J Lipid Res       Date:  1994-04       Impact factor: 5.922

View more
  14 in total

1.  Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranes.

Authors:  Silvina Bartesaghi; Jorge Wenzel; Madia Trujillo; Marcos López; Joy Joseph; Balaraman Kalyanaraman; Rafael Radi
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

Review 2.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

3.  Stretchable electrochemical impedance sensors for intravascular detection of lipid-rich lesions in New Zealand White rabbits.

Authors:  Hung Cao; Fei Yu; Yu Zhao; Nick Scianmarello; Juhyun Lee; Wangde Dai; Nelson Jen; Tyler Beebe; Rongsong Li; Ramin Ebrahimi; Donald S Chang; Freny V Mody; John Pacella; Yu-Chong Tai; Tzung Hsiai
Journal:  Biosens Bioelectron       Date:  2013-12-01       Impact factor: 10.618

Review 4.  Blood flow modulation of vascular dynamics.

Authors:  Juhyun Lee; René R Sevag Packard; Tzung K Hsiai
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

5.  In vitro oxidative footprinting provides insight into apolipoprotein B-100 structure in low-density lipoprotein.

Authors:  Sourav Chakraborty; Yang Cai; Matthew A Tarr
Journal:  Proteomics       Date:  2014-10-09       Impact factor: 3.984

Review 6.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

7.  Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO.

Authors:  Andrea de la Fuente-Alonso; Marta Toral; Alvaro Alfayate; María Jesús Ruiz-Rodríguez; Elena Bonzón-Kulichenko; Gisela Teixido-Tura; Sara Martínez-Martínez; María José Méndez-Olivares; Dolores López-Maderuelo; Ileana González-Valdés; Eusebio Garcia-Izquierdo; Susana Mingo; Carlos E Martín; Laura Muiño-Mosquera; Julie De Backer; J Francisco Nistal; Alberto Forteza; Arturo Evangelista; Jesús Vázquez; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 8.  3-nitrotyrosine modified proteins in atherosclerosis.

Authors:  Leonor Thomson
Journal:  Dis Markers       Date:  2015-03-01       Impact factor: 3.434

9.  Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors:  Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

Review 10.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.